Eversept Partners, LP Gritstone Bio, Inc. Transaction History

Eversept Partners, LP

  • $1.26 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$4.03 - $12.19 $685,603 - $2.07 Million
-170,125 Closed
0 $0
Q4 2021

Nov 08, 2023
BUY
$8.76 - $13.71 $1.49 Million - $2.33 Million
170,125 New
170,125 $2.19 Million
Q4 2021

Feb 14, 2022
BUY
$8.76 - $13.71 $1.49 Million - $2.33 Million
170,125 New
170,125 $2.19 Million

Others Institutions Holding GRTS

# of Institutions
62
Shares Held
35.4M
Call Options Held
395K
Put Options Held
132K
View Full List

About Gritstone bio, Inc.

GRTS Quotes by TradingView
  • Ticker GRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,006,896
  • Market Cap $2.19M
  • Description
  • Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...
More about GRTS
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email